e-z cinnamic acid has been researched along with dinoprostone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Huo, HR; Jiang, TL; Kang, XL; Li, CH; Zhou, J | 1 |
Cai, SQ; Huo, HR; Jiang, TL; Li, CH; Ma, YY; Shang, MY | 1 |
Anauate, MC; de Mello, SB; Torres, LM | 1 |
Chun, W; Kim, SS; Kwon, JH; Lee, HJ; Lee, JW; Lim, MS; Lim, SY | 1 |
Fernandes, E; Janela, J; Proença, C; Ribeiro, D; Roleira, FMF; Tavares da Silva, EJ; Varela, C | 1 |
6 other study(ies) available for e-z cinnamic acid and dinoprostone
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Effect of guizhi tang and its active components on the fever induced by EP3 agonist].
Topics: Acrolein; Analgesics, Non-Narcotic; Animals; Body Temperature; Cinnamates; Dinoprostone; Drug Combinations; Drugs, Chinese Herbal; Fever; Glucosides; Male; Paeonia; Plants, Medicinal; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype | 2003 |
[Structure-activity relationship of phenylallyl compounds inhibiting PGE2 release in mouse cerebral microvascular endothelial cells induced by IL-1beta].
Topics: Acrolein; Animals; Brain; Cells, Cultured; Cinnamates; Dinoprostone; Drugs, Chinese Herbal; Endothelial Cells; Inhibitory Concentration 50; Interleukin-1beta; Mice; Microvessels; Propanols; Structure-Activity Relationship | 2007 |
Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Chemical Analysis; Blood Coagulation; Blood Platelets; Cinnamates; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Etoricoxib; Female; Glycosides; Harpagophytum; Humans; Indomethacin; Inflammation Mediators; Iridoids; Lipopolysaccharides; Nitric Oxide; Plant Extracts; Pyrans; Pyridines; Sulfones; Thromboxane B2 | 2010 |
3,4,5-Trihydroxycinnamic acid increases heme-oxygenase-1 (HO-1) and decreases macrophage infiltration in LPS-induced septic kidney.
Topics: Animals; Cell Line; Cinnamates; Cyclooxygenase 2; Dinoprostone; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Lipopolysaccharides; Macrophages; Membrane Proteins; Mesangial Cells; Mice; Mice, Inbred BALB C; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; Shock, Septic | 2014 |
New phenolic cinnamic acid derivatives as selective COX-2 inhibitors. Design, synthesis, biological activity and structure-activity relationships.
Topics: Amides; Anti-Inflammatory Agents, Non-Steroidal; Cinnamates; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Design; Humans; Leukocytes, Mononuclear; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2019 |